Dr. Ola Landgren shares a clinical trial about smoldering myeloma. Join the REVIVE trial study for high-risk smoldering myeloma study here. (healthtree.org...)
He also share about his research partnership with HealthTree on a personalized medicine study (healthtree.org...) that creates a computerized model of risk prediction and treatment recommendations for newly diagnosed patients.
This is a study that is open to all myeloma patients regardless of where they are being treated. The only involvement by patients is to sign a consent form and connect their medical records which requires less than 5 minutes of participation.